Research on Drugs and Vaccines for COVID-19 Should Be Conducted and Published With Caution.
作者信息
Chen Fei, Gong Shuai, Li Run-Qian
机构信息
Department of Physiology, Jining Medical University.
Department of Animal Genetics Breeding and Reproduction, Shandong Agricultural University.
出版信息
J Epidemiol. 2020 Dec 5;30(12):574-575. doi: 10.2188/jea.JE20200408. Epub 2020 Oct 30.
Abstract
摘要
相似文献
1
Research on Drugs and Vaccines for COVID-19 Should Be Conducted and Published With Caution.
J Epidemiol. 2020 Dec 5;30(12):574-575. doi: 10.2188/jea.JE20200408. Epub 2020 Oct 30.
2
Status of vaccine development for COVID-19.
Br J Community Nurs. 2020 Dec 2;25(12):620-621. doi: 10.12968/bjcn.2020.25.12.620.
3
Revisiting regulatory framework in India for accelerated vaccine development in pandemics with an evidence-based fast-tracking strategy.
Indian J Med Res. 2020;152(1 & 2):156-163. doi: 10.4103/ijmr.IJMR_3640_20.
4
Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More.
JAMA. 2020 Dec 15;324(23):2354-2355. doi: 10.1001/jama.2020.24075.
5
Covid-19: Chinese vaccines may need changes to improve efficacy, admits official.
BMJ. 2021 Apr 13;373:n969. doi: 10.1136/bmj.n969.
6
A COVID-19 vaccine-dare to dream.
Br J Community Nurs. 2020 Dec 2;25(12):2-7. doi: 10.12968/bjcn.2020.25.12.598.
7
Venezuela is collapsing without COVID-19 vaccines.
Lancet. 2021 May 15;397(10287):1806. doi: 10.1016/S0140-6736(21)00924-7.
8
COVID-19 Vaccine Distribution and Allocation: What Physicians Need to Know.
Ann Intern Med. 2021 Mar;174(3):413-414. doi: 10.7326/M21-0331. Epub 2021 Jan 25.
9
A 7-Point Action Agenda to End the COVID-19 Pandemic for President-elect Biden.
JAMA. 2021 Jan 5;325(1):17-18. doi: 10.1001/jama.2020.23848.
10
Covid mutations: honest approach needed from politicians and scientists on pandemic outlook.
BMJ. 2021 Mar 9;372:n656. doi: 10.1136/bmj.n656.
本文引用的文献
1
COVID-19 research: pandemic "paperdemic", integrity, values and risks of the "speed science".
Forensic Sci Res. 2020 Jun 10;5(2):174-187. doi: 10.1080/20961790.2020.1767754. eCollection 2020.
2
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Lancet. 2020 Aug 15;396(10249):467-478. doi: 10.1016/S0140-6736(20)31604-4. Epub 2020 Jul 20.
3
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
N Engl J Med. 2020 Nov 12;383(20):1920-1931. doi: 10.1056/NEJMoa2022483. Epub 2020 Jul 14.
4
Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?
Lancet. 2020 May 22. doi: 10.1016/S0140-6736(20)31174-0.
5
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
Lancet. 2020 May 22. doi: 10.1016/S0140-6736(20)31180-6.
6
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study.
Engineering (Beijing). 2020 Oct;6(10):1192-1198. doi: 10.1016/j.eng.2020.03.007. Epub 2020 Mar 18.
Zotero 插件